New Institute for Health Metrics and Evaluation estimates show global health financing dropped 5% in 2026, following a 12% cut in 2025, as the UK posted the largest absolute reduction …
New Institute for Health Metrics and Evaluation estimates show global health financing dropped 5% in 2026, following a 12% cut in 2025, as the UK posted the largest absolute reduction …
Measles infections in the United States and Mexico have already exceeded all of 2025, with Pennsylvania recording five deaths and more than 1,000 infections as vaccine exemptions reach an all-time …
With 55,792 confirmed measles cases and 77 deaths across the Americas in 2026, PAHO warns that upcoming religious mass gatherings in South America could accelerate transmission in a region where …
A Pan American Health Organization (PAHO) analysis in The Lancet Regional Health – Americas, published in July 2026, finds 470 million people across 38 countries and territories lived with at …
A Mexican health-systems researcher warns that the new scheme could generate more demand than the social-security institutions can absorb, and that far more public investment is indispensable, though not sufficient, …
A study led by Rare Diseases International finds rare disease patients in Colombia wait an average of 25 months for a diagnosis, and up to 19 years in some cases.
Mexico’s pharmaceutical and medical-device industry chamber, Canifarma, says 650–700 medicine listings have been removed from Mercado Libre under a June 2026 brand-protection agreement, and warns that public health-sector medicines are …
Mexico’s public mental health system is severely under-resourced even as nearly five million people in Mexico live with a mental health condition. The Instituto Mexicano del Seguro Social (IMSS) fields …
Brazil’s public health system (SUS) has added extended-release lithium on tolerability and adherence grounds, and the Dominican health-insurance regulator, the Superintendency of Health and Occupational Risks (SISALRIL), is studying wider …
Biolab, a Brazilian pharmaceutical company, has been selected by the UN-backed Medicines Patent Pool to manufacture and sell baloxavir marboxil (Xofluza), Roche’s single-dose oral influenza treatment, in Brazil under a …
You must be logged in to post a comment.